2014
DOI: 10.1530/endoabs.34.p52
|View full text |Cite
|
Sign up to set email alerts
|

Clinical application of the levothyroxine absorption test

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Poor adherence to any medical therapy is a well-known treatment problem in chronic patients (17). Noncompliance to daily administration of LT4 is the most common reason for not responding to the appropriate dose of LT4 (18). "Pseudomalabsorption" due to intentional noncompliance as part of a psychiatric disorder should be considered as illustrated in the literature (11,14,16).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Poor adherence to any medical therapy is a well-known treatment problem in chronic patients (17). Noncompliance to daily administration of LT4 is the most common reason for not responding to the appropriate dose of LT4 (18). "Pseudomalabsorption" due to intentional noncompliance as part of a psychiatric disorder should be considered as illustrated in the literature (11,14,16).…”
Section: Discussionmentioning
confidence: 99%
“…However, there is no gold standard for the LT4 absorption test, and various protocols have been advocated in the literature. The time commitment from a patient ranges from 2 hours to 5 days Test periods ranging from 2 hours to 5 days have been reported (18). We determined our loading test method by measuring FT4 and TSH in blood samples taken before and 1, 2, 3, and 4 hours after LT4 administration, and calculated the maximum FT4 increase.…”
Section: Discussionmentioning
confidence: 99%
“…We herein report a case of uncontrolled primary hypothyroidism due to L-T4 pseudo-malabsorption, documented by a normal L-T4 absorption test and by normalization of TSH following direct-observation L-T4 therapy. Nonadherence to LT4 daily administration is the most common reason for not responding to seemingly appropriate dose of LT4, ultimately leading to diagnosis of pseudo-malabsorption after proper testing (29) In contrast, a key characteristic of LT4 pseudomalabsorption is the patient's denial of poor adherence, leading to obvious challenges in diagnosis and management. 25,26 The L-T4 absorption test is an important tool to consider for distinguishing between nonadherence and true intestinal malabsorption (after excluding gastrointestinal and liver diseases, medication and dietary interference), the latter of which is very rare.…”
Section: Discussionmentioning
confidence: 99%
“…The time commitment from a patient ranges from 2 h to 5 days. 2830 We elected to utilize a rapid, 2-h test. Adequate absorption of L-T4 was demonstrated with a subsequent prominent spike in free T4 plasma levels and concomitant suppression of TSH.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with persistently elevated TSH levels, there are a number of causes, which needs to be considered, including poor administration and pathological malabsorption conditions. However, the literature is not clear on the actual degree of malabsorption, in each malabsorptive condition 11 .In the majority of the cases, the combination of history and examination identifies biological causes of LT4 malabsorption. Therefore, before more detailed investigations, the issue of adherence needs to be addressed 2 .…”
Section: Discussionmentioning
confidence: 99%